Structural Aspects of <i>Mycobacterium tuberculosis</i> DNA Gyrase Targeted by Novel Bacterial Topoisomerase Inhibitors

In this Letter, we present a small series of novel bacterial topoisomerase inhibitors (NTBIs) that exhibit both potent inhibition of <i>Mycobacterium tuberculosis</i> DNA gyrase and potent antimycobacterial activity. The disclosed crystal structure of <i>M. tuberculosis</i> DNA gyrase in complex with DNA and compound <b>5</b> from this NBTI series reveals the binding mode of an NBTI in the GyrA binding pocket and confirms the presence and importance of halogen bonding for the excellent on-target potency. In addition, we have shown that compound <b>5</b> is a promising <i>M. tuberculosis</i> DNA gyrase inhibitor, with an IC<sub>50</sub> for <i>M. tuberculosis</i> gyrase of 0.096 μM, and it has potent activity against <i>M. tuberculosis</i>, with an IC<sub>50</sub> of 0.165 μM.

Authors

Institutions

Publication Details

Journal
ACS Medicinal Chemistry Letters
Published
2024-11-22
DOI
https://doi.org/10.1021/acsmedchemlett.4c00447
Citations
4
Primary Topic
Cancer therapeutics and mechanisms
Type
article
Field-Weighted Citation Impact
0.94

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Structural Aspects of Mycobacterium tuberculosis DNA Gyrase Targeted by Novel Bacterial Topoisomerase Inhibitors

Marko Anderluh, Martina Hrast, Tanya Parish, Nikola Minovski et al.
4 citations
ACS Medicinal Chemistry Letters
Cancer therapeutics and mechanisms
0.94
article

Structural Aspects of Mycobacterium tuberculosis DNA Gyrase Targeted by Novel Bacterial Topoisomerase Inhibitors

Marko Anderluh, Martina Hrast, Tanya Parish, Nikola Minovski, Lipeng Feng, David M. Lawson, Anthony Maxwell, Lesley A. Mitchenall, Maja Kokot
article en
4 citations

Abstract

In this Letter, we present a small series of novel bacterial topoisomerase inhibitors (NTBIs) that exhibit both potent inhibition of <i>Mycobacterium tuberculosis</i> DNA gyrase and potent antimycobacterial activity. The disclosed crystal structure of <i>M. tuberculosis</i> DNA gyrase in complex with DNA and compound <b>5</b> from this NBTI series reveals the binding mode of an NBTI in the GyrA binding pocket and confirms the presence and importance of halogen bonding for the excellent on-target potency. In addition, we have shown that compound <b>5</b> is a promising <i>M. tuberculosis</i> DNA gyrase inhibitor, with an IC<sub>50</sub> for <i>M. tuberculosis</i> gyrase of 0.096 μM, and it has potent activity against <i>M. tuberculosis</i>, with an IC<sub>50</sub> of 0.165 μM.

ACS Medicinal Chemistry LettersVol. 15(12)
John Innes Centre (GB), Infectious Disease Research Institute (US), University of Ljubljana (SI), University of Washington (US), Norwich Research Park (GB), National Institute of Chemistry (SI)
Fred Hutchinson Cancer Research Center, University of Washington, Seattle Children's Research Institute, Children’s Hospital of Wisconsin Research Institute, Diamond Light Source, Javna Agencija za Raziskovalno Dejavnost RS, Center for AIDS Research, University of Washington, Biotechnology and Biological Sciences Research Council, National Institute of Allergy and Infectious Diseases
Zero hunger
Openalex Percentile: Top 25%
Cancer therapeutics and mechanisms
0.94
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.